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In the era of the evidence based medicine, the results of the clinical trials
occupy an important, always increasing, place within the knowledge necessary
for medical practice. In spite of the considerable progress realized in the appli-
cation of the results of the trials, certain number of difficulties remains, in par-
ticular those of the accessibility to their results.
TrialResults-center is a knowledge database storing all the results of the cli-
nical trials and providing access to systematic review and meta-analysis of all
randomized clinical trials about all major heart and vessels diseases. The Tria-
lResults-center database provides a unique view of the treatment efficacy
based on all data provided directly from clinical trial results, offering a
valuable alternative to personal bibliographic search, published meta-analysis,
etc. Furthermore, it would allow comparing easily the various concurrent the-
rapeutic for the same clinical condition.
Rigorous meta-analysis’ method is used to populate TrialResults-center:
widespread search of published and non published trials, study selection using
pre-specified criteria, data extraction using standard form.
TrialResults-center is continually updated on a weekly basis. We conti-
nually search all new results (whatever their publication channel) and these
news results are immediately added to the database with a maximum of 1
week.
This is a public and non-profit service.
TrialResults-center contributors use custom authoring tools to upload the
trial description and results. This information is stored in a series of databases,
and web pages are created dynamically. This system provides great flexibility
in the presentation of information. It supports the customization of content for
different audiences and the sharing of materials with other projects.
The TrialResults-center’s scientific content is backed by a rigorous quality
control system.
TrialResults-center is accessible at the address: www.trialresultscenter.org
055
The INDYCE Survey. Prevalence of left ventricular systolic dysfunc-
tion in stable coronary artery disease patients: Systolic ventricular
function assessment is necessary in stable CAD patients
Marie Christine Malergue (1), Maxime Guenoun (2), Franck Paganelli (3),
Patrick Jourdain (4), Yves Alamercery (5), Philippe Meurin (6), Domini-
que Guedj (7)
(1) Institut Jacques Cartier, Massy, France – (2) Hopital Nord et Collège
National des Cardiologues Français, Marseille, France – (3) Hopital
Nord, Cardiologie, Marseille, France – (4) Centre Hospitalier, Pontoise,
France – (5) RCTS, service de statistiques, Lyon, France – (6) les grands
prés, cardiologie, Villeneuve Saint Denis, France – (7) Cabinet de Car-
diologie et Collège National des Cardiologues Français, Paris, France
Background: It is well recognized that left ventricular function is a crucial
factor influencing management and prognosis in coronary artery disease
(CAD).Little is known however about left ventricular ejection fraction (LVEF)
distribution in stable CAD patients.
Objective: To evaluate LVEF in stable CAD outpatients in France
Methods: The INDYCE survey was conducted in a sample of 343 cardiolo-
gists in 2008) . Each physician had to include consecutively 10 stable (absence
of acute coronary syndrome or revascularisation in the 6 months preceding
enrolment) CAD patients. LVEF measurement (with the biplane simpson
method) was the main endpoint of the survey.
Results: 3 119 patients were enrolled. Medical therapy was in keeping with
Guidelines. Patients suffered from mild to moderate symptoms (Table).
Mean LVEF was 56 ± 11 %; poor (LVEF < 40 %) and moderately
impaired (40 ≤ LVEF ≤ 50%) systolic ventricular function were reported in
9.6% (n = 298) and 19.8 % (n = 619) of the cases respectively. 14 % of the
patients with LVEF < 40 %, 29.4 % of the patients with 40 ≤ LVEF ≤
50% and 47.3 % of the patients with LVEF > 50 % were completely asymp-
tomatic (i.e no angina and NYHA class 0 or I).
Conclusion: Among stable CAD patients, even if LVEF is globally pre-
served , about 30 % of the patients have a moderate or severe left ventricular
systolic dysfunction. It can be completely asymptomatic and therefore unreco-
gnized in some patients although it should modify prognosis and manage-
ment . This suggests that regular systolic ventricular function assessment is
necessary in stable CAD patients.
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